Teleflex (TFX)
(Delayed Data from NYSE)
$211.17 USD
+0.06 (0.03%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $211.16 -0.01 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth C Momentum D VGM
Price, Consensus and EPS Surprise
TFX 211.17 +0.06(0.03%)
Will TFX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for TFX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TFX
Teleflex (TFX) Debuts the New Unified UroLift 2 System With ATC
Is ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) a Strong ETF Right Now?
TFX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain Teleflex (TFX) Stock for Now
Should ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) Be on Your Investing Radar?
Teleflex (TFX) Q4 Earnings Top Estimates, Operating Margin Falls
Other News for TFX
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
RBC Capital Sticks to Its Buy Rating for Teleflex (TFX)
(TFX) - Analyzing Teleflex's Short Interest
DDL Expands its Offerings with Addition of Consulting Services Focused on Packaging Process Development
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types